Optimal Life Journal
Thoughtful, evidence-aware perspectives to help you ask better questions and make informed decisions with your healthcare provider.
From the journal
Peptide Sciences was a well-known supplier of research peptides in the United States. Many laboratories and researchers used the company because of its broad catalog and established reputation. However, Peptide Sciences has now announced that it is voluntarily shutting down its operations. The company has also discontinued the sale of its research products. This has […]
Quick Answer The activation of the three major metabolic receptors at a time makes Retatrutide a triple agonist, and they are : This multiple receptor interaction provides an opportunity for researchers to examine how the interactions of signaling pathways affect energy homeostasis, endocrine function, and biological processes in a controlled laboratory setting. Retatrutide is an […]
Short Answer: No, legally you cannot buy Eli Lilly’s Retatrutide in June 2026. Retatrutide is an investigational peptide in Phase 3 clinical trials. Neither the FDA nor any other major regulatory agency has approved Retatrutide for human consumption yet. According to Eli Lilly, Retatrutide is legally available only through authorized clinical trials. For research purposes, […]
GHK-Cu (Glycyl-L-Histidyl-L-Lysine Copper) has emerged as one of the most popular regenerative peptides in 2026. First isolated in human plasma back in 1973, the naturally occurring copper-binding tripeptide has gained popularity among scientists, dermatologists, and those interested in longevity for its ability to repair tissue, promote collagen production, heal wounds, and reduce inflammation. Unlike other […]
Yes, Peptide Sciences has stopped selling peptides and closed down its operations in March 2026. The sudden closure of Peptide Sciences has left many loyal Peptide Sciences customers in a confusing state, unable to choose their next peptide supplier. For years, Peptide Sciences was a well-known source for research peptides like BPC-157, TB-500, CJC-1295, Ipamorelin, […]
In early 2026, many researchers suddenly realized that the Peptide Sciences website was no longer working. The company had been active for several years and was known among researchers who purchased peptides for laboratory studies. Because of that, the sudden disappearance of the website created confusion. Many people began searching online to understand what had […]
2026 has turned into a rollercoaster year for peptide enthusiasts and vendors. Just as the year began, news surfaced that Science Bio had shut down its operations, leaving many researchers and customers searching for alternatives. A couple of months later, another major name in the industry, Peptide Sciences, also reportedly closed its operations, creating an […]
The U.S. FDA is starting a new review process for 12 peptides that were previously restricted. This decision comes after support from Robert F. Kennedy Jr., who said the goal is to restore science, accountability, and proper regulation. The announcement has also gained attention after Donald Trump Jr. publicly supported the move, calling it “Amazing […]
The peptide industry may be on the verge of a major shift. Robert F. Kennedy Jr. has publicly supported a move to reconsider several peptides that were restricted by the FDA in 2023. Now, the agency is preparing to review these compounds again, signaling a possible change in policy that could impact patients, clinics, and […]
Over the last two months, things have been rapidly changing in the peptide world. Just 4 weeks ago, the big peptide vendors, Peptide Sciences, got shot down, and now Amazon has taken down BAC water, which plays an important role in the research. In addition to increasing curiosity among researchers about what is happening, it […]
In January 2026, peptide researchers got disappointing news when Science Bio shut down. For years, it was the first choice for research peptides for many researchers. But that’s an old story now. Research does not stop. The real challenge is finding a new and reliable peptide supplier that offers high-purity products and provides a certificate […]
Semax is a synthetic heptapeptide analog of ACTH(4-10) that was developed in Russia, where it has been sufficiently studied as an experimental nootropic compound in laboratory models for its neuroprotective and cognitive-modulating properties. It is made up of the sequence Met-Glu-His-Phe-Pro-Gly-Pro and is usually sold in lyophilized vials for laboratory research purposes. Animal models, as […]
